Abstract
Semen analyses carried out as part of the clinical in vitro fertilization or intrauterine insemination protocols provide important information that determine the type of clinical treatment of the male partner and the sperm processing method. It is postulated that the sperm of male-factor patients cannot survive hypoosmotic stress conditions because of defective sperm membrane function. To test this, 0.1 ml of semen from each of 102 patients was placed in 1.0 ml of 150 mosmolliter eosin citrate fructose solution and incubated for 30 min at 37°C. The percentage viability of the sperm cells was then determined. The results indicated that patients with two or more abnormal semen parameters had a significantly lower percentage viability while in the hypoosmotic solution (40.6±4.7%), in contrast to non-male-factor patients (69.0±1.6%). Donor sperm (N=32) serving as controls (73.3±2.1%) had a viability in hypoosmotic solution similar to that of non-male-factor patients. The data suggest that sperm of male-factor patients are less able to survive the hypoosmotic stress conditions as shown by the percentage viability in hypoosmotic solution and emphasize the impertance of using less stressful sperm processing methods for in vitro fertilization or insemination in these patients.
Similar content being viewed by others
References
Jeyendram RS, Van der Ven HH, Perez-Pelaez M, Crabo BG, Zaneveld LJD: Development of an assay to assess the functional integrity of the human sperm membrane and its relationship to other semen characteristics. J Reprod Fert 1984;70:219, 1984
Parikh FR, Lavy G, DeCherney AH: The hypoosmotic swelling test as a predictor of in vitro fertilization outcome.In Proceedings of the 36th Annual Meeting of the Society for Gynecological Investigation, San Diego, Calif, 1989, p 321, abstr 479
World Health Organization: WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. Cambridge, Cambridge University Press, 1987
American Fertility Society: New guidelines for the use of semen-donor insemination: 1986. Fertil Steril 1986;46: Suppl 2
Eliasson R: Supravital staining of human spermatozoa. Fertil Steril 1977;28:1257
Chan PJ, Henig I, Tredway DR, Prough SG: Simplified method for evaluating sperm hyperactivation based on dilution effect versus washed sperm method. J Androl 1989; 10:30P
Zaneveld LJD, Jeyendran RS, Ktakeski P, Coetzee K, Kruger TF, Lombard CJ: Hypoosmotic swelling test.In Human Spermatozoa in Assisted Reproduction, AA Acosta, RJ Swanson, SB Ackerman, TF Kruger, JA van Zyl, R Menkveld (eds.) Baltimore, Williams and Wilkins, 1990, p 223
Makler A, Murillo O, Huszar G, Tarlatzis B, DeCherney A, Naftolin F: Improved techniques for separating motile spermatozoa from human semen. II. An atraumatic centrifugation method. Int J Androl 1984;7:71
Chan SYW, Fox EJ, Chan MMC, Tsoi W, Tang LCM, Tang GWK, Ho P: The relationship between the human sperm hypoosmotic swelling test, routine semen analysis, and the human zona-free hamster ovum penetration test. Fertil Steril 1985;44:668
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chan, P.J., Tredway, D.R., Su, B.C. et al. Identification of male-factor semen samples prior to insemination and in vitro fertilization. J Assist Reprod Genet 8, 37–40 (1991). https://doi.org/10.1007/BF01131589
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01131589